Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

Press releases published on April 1, 2026

Apr. 1, 2026

Alignment Healthcare to Present at the BofA Securities Health Care Conference 2026

Indeterminate GlobeNewswire

Apr. 1, 2026

New global report reveals men and young adults driving soaring usage of wellness technologies

Indeterminate GlobeNewswire

Apr. 1, 2026

Picard Medical / SynCardia to Participate in Voice of the Patient Event During AZ Tech Week

Indeterminate GlobeNewswire

Apr. 1, 2026

Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets

Indeterminate GlobeNewswire

Apr. 1, 2026

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Indeterminate GlobeNewswire

Apr. 1, 2026

Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Apr. 1, 2026

Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Indeterminate GlobeNewswire

Apr. 1, 2026

JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)

Indeterminate GlobeNewswire

Apr. 1, 2026

Cost concerns now rival fear of cancer diagnosis, new survey finds

Indeterminate GlobeNewswire

Apr. 1, 2026

Axe Compute Reports $12 Million in Executed Agreements Providing $835 Thousand in Estimated Monthly Income Entering Q2 2026

Indeterminate GlobeNewswire

Apr. 1, 2026

Trevi Therapeutics to Participate in Upcoming Events

Indeterminate GlobeNewswire

Apr. 1, 2026

Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines

Indeterminate GlobeNewswire

Apr. 1, 2026

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

Indeterminate GlobeNewswire

Apr. 1, 2026

Avicanna Reports Full Year 2025 Audited Financial Statements

Indeterminate GlobeNewswire

Apr. 1, 2026

MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference

Indeterminate GlobeNewswire

Apr. 1, 2026

NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing

Indeterminate GlobeNewswire

Apr. 1, 2026

A Kaleidoscope Inspires the Foundation for Sarcoidosis “See Sarcoidosis” Global Campaign for Sarcoidosis Awareness Month

Indeterminate GlobeNewswire

Apr. 1, 2026

Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease

Indeterminate GlobeNewswire

Apr. 1, 2026

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity

Indeterminate GlobeNewswire

Apr. 1, 2026

AAVantgarde appoints Philip Lao as Senior Vice President of Business Development

Indeterminate GlobeNewswire